NPTE Pharmacology Practice Test

Insulin therapy is effective in the management of hyperkalemia because it facilitates the movement of potassium from the bloodstream into the cells, thereby temporarily lowering serum potassium levels. This occurs because insulin promotes the activity of the sodium-potassium ATPase pump, which helps to shift potassium intracellularly. The effect is rapid and can quickly alleviate high potassium levels, making it a common acute treatment choice in hyperkalemia, especially in emergency settings.

While loop diuretics, beta-agonists, and calcium supplements might also be relevant in certain scenarios related to potassium management or complications arising from hyperkalemia, they do not act as directly or as effectively as insulin in lowering serum potassium levels in an acute situation. Loop diuretics can help by increasing potassium excretion through urine, but this takes longer to increase potassium levels back to normal. Beta-agonists can also promote the uptake of potassium into cells but are less reliable and less frequently used solely for hyperkalemia. Calcium supplements are typically used to stabilize cardiac function in the presence of elevated potassium levels rather than to lower potassium itself.